Facing Brexit, U.K. Makes Science Deal with U.S.

The $88 million agreement is part of efforts by the UK government to increase transatlantic collaboration as the country prepares to leave the European Union.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, LEPETTETThe U.K. has committed $88 million to a new collaboration dubbed the UK-US Science and Technology Agreement, the UK government announced on Wednesday (September 20). Signed by UK science minister Jo Johnson and US State Department official Judith Garber, the agreement outlines the countries’ commitments to cooperation on scientific research, and is part of a larger effort by the UK government to strengthen transatlantic ties amidst fears that British science will take a hit after Brexit.

The deal “involves us in one of the most exciting new physics experiments in the world,” Johnson tells ScienceInsider. “We’re delighted to be a part of it.”

The Deep Underground Neutrino Experiment (DUNE) aims to use particle accelerators to advance scientists’ understanding of the structure and origin of the universe. The U.K. is already involved in the project, and has 150 of its scientists working as part of a 1,000-researcher strong program based in the U.S. But the current investment will make the U.K. the largest financial contributor after the States, Times Higher Education reports.

“This agreement sends a welcome message that UK science remains outward looking,” Venki Ramakrishnan, president of the Royal Society, tells the BBC. “International research collaboration allows the rapid exchange of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies